Keeping You Connected

The SFMMS keeps you up to date on the latest news,
policy developments, and events

San Francisco Marin Medical Society Blog

rss

Coalition of Health Care Organizations Issues Joint Letter Opposing Governor's Dual Eligible Proposal

In an open letter to members of the California State Legislature, nearly twenty organizations representing a wide variety of health care stakeholders urged their representatives to oppose Governor Brown’s dual eligible proposal. The proposal would move patients eligible for both Medicare and Medi-Cal into a Medi-Cal Managed Care program, ultimately disrupting care and harming patients.

Considering BPA: State of the Art or Willful Ignorance?

While it is technically correct that the FDA did not ban bisphenol A (BPA), the Wall Street Journal misled readers when it ignored the clear FDA statements that we need to reduce BPA exposure of our most vulnerable citizens. This is a prototype example of the spin-versus-spin arguments that characterize most of the environmental chemical debate. These arguments are not about truth. They are about control of public perception. It is time for willful efforts to skip the spin, outline the challenges, and answer the questions that affect the safety of our children and grandchildren.

5010 Format Required for Electronic Claims Beginning July 1

The deadline for transitioning electronic transactions to the updated 5010 version of the Health Insurance Portability and Accountability Act (HIPAA) transactions standards is July 1, 2012. You will be required to conduct electronic transactions such as claims submissions, eligibility verification, claims status, remittance advice and referral authorizations using the updated transaction standards.

Environmental Chemicals: Large Effects from Low Doses

As research has expanded into the effects of endocrine-disrupting chemicals (EDCs), it has been shown that they follow the same rules that hormones follow. Unfortunately, this runs counter to the core assumption that forms the basis for all toxicological testing done to establish regulatory standards: High-dose testing will be informative about low-dose impacts.

Archives